Central Trust Company’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.53K | Sell |
36
-40
| -53% | -$5.03K | ﹤0.01% | 1226 |
|
|
2025
Q1 | $8.41K | Sell |
76
-10
| -12% | -$1.11K | ﹤0.01% | 1138 |
|
|
2024
Q4 | $11.7K | Buy |
86
+10
| +13% | +$1.37K | ﹤0.01% | 1073 |
|
|
2024
Q3 | $8.76K | Hold |
76
| – | – | ﹤0.01% | 1084 |
|
|
2024
Q2 | $10.5K | Hold |
76
| – | – | ﹤0.01% | 1059 |
|
|
2024
Q1 | $10.5K | Hold |
76
| – | – | ﹤0.01% | 1073 |
|
|
2023
Q4 | $10K | Sell |
76
-60
| -44% | -$7.91K | ﹤0.01% | 1075 |
|
|
2023
Q3 | $15.3K | Buy |
136
+36
| +36% | +$4.05K | ﹤0.01% | 974 |
|
|
2023
Q2 | $9.43K | Sell |
100
-245
| -71% | -$23.1K | ﹤0.01% | 1036 |
|
|
2023
Q1 | $34.9K | Sell |
345
-62
| -15% | -$6.28K | ﹤0.01% | 852 |
|
|
2022
Q4 | $48.6K | Sell |
407
-15
| -4% | -$1.79K | ﹤0.01% | 773 |
|
|
2022
Q3 | $45K | Buy |
+422
| New | +$45K | ﹤0.01% | 789 |
|
|
2020
Q3 | – | Sell |
-250
| Closed | -$31K | – | 1092 |
|
|
2020
Q2 | $31K | Hold |
250
| – | – | ﹤0.01% | 694 |
|
|
2020
Q1 | $22K | Hold |
250
| – | – | ﹤0.01% | 742 |
|
|
2019
Q4 | $27K | Hold |
250
| – | – | ﹤0.01% | 775 |
|
|
2019
Q3 | $23K | Buy |
+250
| New | +$23K | ﹤0.01% | 774 |
|